These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 2766287)
61. The demonstration of progesterone, but not of estrogen, receptors in the developing human placenta. Rossmanith WG; Wolfahrt S; Ecker A; Eberhardt E Horm Metab Res; 1997 Dec; 29(12):604-10. PubMed ID: 9497895 [TBL] [Abstract][Full Text] [Related]
62. [An immunohistochemical investigation of estrogen receptor in human breast cancer]. Hori M; Furusato M; Aizawa S; Tanaka H; Uchida K Gan No Rinsho; 1990 Feb; 36(2):143-7. PubMed ID: 1689780 [TBL] [Abstract][Full Text] [Related]
63. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis]. Scharl A; Vierbuchen M; Würz H Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630 [No Abstract] [Full Text] [Related]
64. Estrogen receptors and human bone cells: immunocytochemical studies. Colston KW; King RJ; Hayward J; Fraser DI; Horton MA; Stevenson JC; Arnett TR J Bone Miner Res; 1989 Aug; 4(4):625-31. PubMed ID: 2479230 [TBL] [Abstract][Full Text] [Related]
65. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors. Masood S; Lu L; Rodenroth N Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213 [TBL] [Abstract][Full Text] [Related]
66. Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers. Helin HJ; Helle MJ; Helin ML; Isola JJ Am J Clin Pathol; 1988 Aug; 90(2):137-42. PubMed ID: 2456008 [TBL] [Abstract][Full Text] [Related]
67. Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases. Tóth J; De Sombre ER; Greene GL Zentralbl Pathol; 1991; 137(3):227-32. PubMed ID: 1931896 [TBL] [Abstract][Full Text] [Related]
68. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Press MF; Xu SH; Wang JD; Greene GL Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797 [TBL] [Abstract][Full Text] [Related]
69. Determination of estrogen receptors in cytologic imprints of breast cancers using immunocytochemical methods. Deligeorgi-Politi H; Bartziota EV; Mavrogeorgis A; Sekeris CE Acta Cytol; 1990; 34(6):881-4. PubMed ID: 1701608 [TBL] [Abstract][Full Text] [Related]
70. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. Wilbur DC; Willis J; Mooney RA; Fallon MA; Moynes R; di Sant'Agnese PA Mod Pathol; 1992 Jan; 5(1):79-84. PubMed ID: 1371874 [TBL] [Abstract][Full Text] [Related]
71. [Enzymo-immunoassay of progesterone receptors in human breast lesions and tumors. Comparison with a biochemical method]. Delarue JC; Bertin F; May-Levin F; Mouriesse H Bull Cancer; 1989; 76(3):329-32. PubMed ID: 2660942 [TBL] [Abstract][Full Text] [Related]
72. Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method. Lacombe MJ; Delarue JC; Mouriesse H; Contesso G; Friedman S; Sancho-Garnier H; Travagli JP; May-Levin F Gynecol Oncol; 1989 Feb; 32(2):174-9. PubMed ID: 2910778 [TBL] [Abstract][Full Text] [Related]
73. [Preoperative immunocytochemical estrogen receptor determination in fine needle aspirates in breast cancer using monoclonal antibodies]. Kübler HC; Kühn W; Rummel HH; Krapfl E; Klinga K Geburtshilfe Frauenheilkd; 1988 Nov; 48(11):763-7. PubMed ID: 3234709 [TBL] [Abstract][Full Text] [Related]
74. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay. Gritzapis AD; Baxevanis CN; Missitzis I; Katsanou ES; Alexis MN; Yotis J; Papamichail M Breast Cancer Res Treat; 2003 Jul; 80(1):1-13. PubMed ID: 12889594 [TBL] [Abstract][Full Text] [Related]
75. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Kinsel LB; Szabo E; Greene GL; Konrath J; Leight GS; McCarty KS Cancer Res; 1989 Feb; 49(4):1052-6. PubMed ID: 2643460 [TBL] [Abstract][Full Text] [Related]
76. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Brustein S; Fruchter R; Greene GL; Pertschuk LP Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614 [TBL] [Abstract][Full Text] [Related]
77. [Estrogen and progesterone receptors in esophageal carcinoma cells]. Wang LY Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):23-5. PubMed ID: 1889335 [TBL] [Abstract][Full Text] [Related]
78. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data. Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956 [TBL] [Abstract][Full Text] [Related]
79. Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Press MF; Greene GL Endocrinology; 1988 Mar; 122(3):1165-75. PubMed ID: 3342750 [TBL] [Abstract][Full Text] [Related]
80. Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Giani C; D'Amore E; Delarue JC; Mouriesse H; May-Levin F; Sancho-Garnier H; Breccia M; Contesso G Int J Cancer; 1986 Jan; 37(1):7-10. PubMed ID: 3000957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]